BSE filing, NSE: RAGHUNAT. Summary written from the filing by ALFA Finder's alert engine.
Raghunath International Ltd: key numbers
- Share price
- ₹10.00
- Market cap
- ₹5.00 Cr
- Revenue (annual)
- ₹0.85 Cr
- Net profit (annual)
- ₹1.05 Cr
- P/E (TTM)
- 10.4×Sector 38.0×
- Promoter holding
- 41.30%+0.09% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raghunath International Ltd
All →Raghunath International Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 85.7% YoY
Raghunath International Ltd reported net profit of ₹0.1 Cr (-85.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr · -85.7% YoY
Raghunath International Other Announcement
Raghunath International disclosed its Q2 FY27 shareholding pattern, with part of promoter holding still in physical form. The company says duplicate certificates and dematerialisation are underway.
Raghunath International Board Meeting Date
Raghunath International will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. The trading window closes from 01 Oct 2026 until 48 hours after results are published.
Raghunath International Other Announcement
Company submitted its quarterly shareholding pattern and clarified that some promoter shares remain in physical form due to lost certificates, with dematerialization currently in progress.
Raghunath International Management Change
Raghunath International Limited shareholders approved the regularization of Mr. Sunil Singh as Independent Director and Mr. Abhinav Nautiyal as Non-Executive Director. Both appointments are effective September 29, 2026.
- Execution
- 5 consecutive years
Raghunath International Annual General Meeting
Raghunath International Limited held its 32nd Annual General Meeting on September 29, 2026, where shareholders approved financial statements, director appointments, and borrowing powers.
Other financial results announcements
All →Kwality Pharmaceuticals Q2 FY27 Results: Net Profit ₹29 Cr, Up 105.7% YoY
Kwality Pharmaceuticals Ltd reported revenue from operations of ₹181.2 Cr (+63.1% YoY) and net profit of ₹29 Cr (+105.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹29 Cr · +105.7% YoY
Taj GVK Hotels & Resorts Q2 FY27 Results: Net Profit ₹26.6 Cr, Down 3.6% YoY
Taj GVK Hotels & Resorts Ltd reported revenue from operations of ₹166.8 Cr (+55.6% YoY) and net profit of ₹26.6 Cr (-3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · -3.6% YoY
Cura Technologies Q2 FY27 Results: Net Loss of ₹0.2 Cr
Cura Technologies Ltd reported a net loss of ₹0.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.2 Cr
Sugal & Damani Share Brokers Q2 FY27 Results: Net Profit ₹0.5 Cr, Down 61.5% YoY
Sugal & Damani Share Brokers Ltd reported revenue from operations of ₹6 Cr (+1.7% YoY) and net profit of ₹0.5 Cr (-61.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.5 Cr · -61.5% YoY
Murudeshwar Ceramics Q2 FY27 Results: Net Profit ₹1.5 Cr, Down 53.1% YoY
Murudeshwar Ceramics Ltd reported revenue from operations of ₹56.3 Cr (+23.5% YoY) and net profit of ₹1.5 Cr (-53.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.5 Cr · -53.1% YoY
Sunil Agro Foods Q2 FY27 Results: Net Profit ₹0.4 Cr, Up 300.0% YoY
Sunil Agro Foods approved unaudited Q2FY27 and half-year results ending 30 Sep 2026. The full Reg 33 financial statement and review report are enclosed.
- Key figure
- Net profit ₹0.4 Cr · +300.0% YoY